Bone health in cancer: ESMO Clinical Practice Guidelines
2020 · Annals of Oncology · 492 citations
https://doi.org/10.1016/j.annonc.2020.07.019
P
Peyman Hadji
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
297
Papers
9.3K
Citations
48
h-index
138
i10-index
Peyman Hadji is an academic researcher from Cardiovascular Center Frankfurt. The author has contributed to research in topics: Bone health and treatments & Estrogen and related hormone effects & Bone health and osteoporosis research. The author has an h-index of 48, co-authored 253 publications.
ORCID: 0000-0001-5228-6387Papers by this author
worksPrognostic effect of low-level HER2 expression in patients with clinically negative HER2 status
2021 · European Journal of Cancer · 86 citations
https://doi.org/10.1016/j.ejca.2021.06.033
Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer
2021 · Journal of bone oncology · 77 citations
https://doi.org/10.1016/j.jbo.2021.100355
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
2016 · Osteoporosis International · 51 citations
https://doi.org/10.1007/s00198-016-3623-6
Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor‐positive, human epidermal growth factor receptor 2‐negative locally advanced or metastatic breast cancer: Results of the single‐arm, phase IIIB 4EVER trial
2018 · International Journal of Cancer · 42 citations
https://doi.org/10.1002/ijc.31738
Dickkopf-1 is regulated by the mevalonate pathway in breast cancer
2014 · Breast Cancer Research · 36 citations
https://doi.org/10.1186/bcr3616
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat